Conference Coverage
Conference Coverage
New research holds promise for fighting obesity, says expert
A growing understanding of adipose tissue as an endocrine organ responsible for weight control opens avenues for treatment, she says.
Conference Coverage
Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival
Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class...
Conference Coverage
Better survival in older cancer patients who take metformin
“It is important to explore optimal dosages that significantly improve cancer outcomes to boost anticancer effect.”
Conference Coverage
High comorbidity rate seen before osteoarthritis diagnosis
More than 40 medical conditions were positively associated with having a new diagnosis of osteoarthritis in a large, nested case-control study.
Conference Coverage
Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patients
Empagliflozin showed symptomatic benefits in patients hospitalized for acute heart failure after 2 weeks in a secondary analysis from the EMPULSE...
Conference Coverage
Type 2 diabetes remission possible for those with lower BMI
Having a normal BMI is no barrier to experiencing type 2 diabetes remission with a structured weight-loss program, show U.K. results.
News
Could AI tool identify type 1 diabetes earlier in childhood?
In the U.K., approximately 25% of children with type 1 diabetes are diagnosed while they are in diabetic ketoacidosis, a figure that has remained...
Conference Coverage
New HF guidelines feature ‘quad’ therapy, tweaked terminology
They include new generalist-friendly labels for the traditional but obscurely named four stages of HF that, it is hoped, will have wider reach and...
Conference Coverage
SCORED: Sotagliflozin shows robust MACE benefit
Trial results in patients with diabetes, CKD, and high CVD risk showed robust benefits across MACE outcomes, distinguishing sotagliflozin from the...
Conference Coverage
Below the belt: sexual dysfunction overlooked in women with diabetes
The most commonly reported issues were decreased sexual desire, lubrication problems, orgasmic dysfunction, and pain.